Is aspirin associated with an increased pancreatic cancer risk?

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2004

Schlagwörter:	High Risk Aspirin Relative Risk Pancreatic Cancer Cancer Risk

Anmerkung:	© Adis International Ltd 2004

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1421(2004), 1 vom: Jan., Seite 21-21
Übergeordnetes Werk:	volume:1421 ; year:2004 ; number:1 ; month:01 ; pages:21-21

Links:	Volltext

DOI / URN:	10.2165/00128413-200414210-00055

Katalog-ID:	SPR035177209

Internformat


LEADER	01000caa a22002652 4500
001	SPR035177209
003	DE-627
005	20230519235324.0
007	cr uuu---uuuuu
008	201007s2004 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200414210-00055 \|2 doi
035			\|a (DE-627)SPR035177209
035			\|a (SPR)00128413-200414210-00055-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Is aspirin associated with an increased pancreatic cancer risk?
264		1	\|c 2004
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2004
650		4	\|a High Risk \|7 (dpeaa)DE-He213
650		4	\|a Aspirin \|7 (dpeaa)DE-He213
650		4	\|a Relative Risk \|7 (dpeaa)DE-He213
650		4	\|a Pancreatic Cancer \|7 (dpeaa)DE-He213
650		4	\|a Cancer Risk \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1421(2004), 1 vom: Jan., Seite 21-21 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1421 \|g year:2004 \|g number:1 \|g month:01 \|g pages:21-21
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200414210-00055 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_206
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_4305
951			\|a AR
952			\|d 1421 \|j 2004 \|e 1 \|c 01 \|h 21-21

Indexfelder

matchkey_str	article:22306056:2004----::ssiiascaewtaicesdac
hierarchy_sort_str	2004
publishDate	2004
allfields	10.2165/00128413-200414210-00055 doi (DE-627)SPR035177209 (SPR)00128413-200414210-00055-e DE-627 ger DE-627 rakwb eng Is aspirin associated with an increased pancreatic cancer risk? 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 High Risk (dpeaa)DE-He213 Aspirin (dpeaa)DE-He213 Relative Risk (dpeaa)DE-He213 Pancreatic Cancer (dpeaa)DE-He213 Cancer Risk (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1421(2004), 1 vom: Jan., Seite 21-21 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1421 year:2004 number:1 month:01 pages:21-21 https://dx.doi.org/10.2165/00128413-200414210-00055 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1421 2004 1 01 21-21
spelling	10.2165/00128413-200414210-00055 doi (DE-627)SPR035177209 (SPR)00128413-200414210-00055-e DE-627 ger DE-627 rakwb eng Is aspirin associated with an increased pancreatic cancer risk? 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 High Risk (dpeaa)DE-He213 Aspirin (dpeaa)DE-He213 Relative Risk (dpeaa)DE-He213 Pancreatic Cancer (dpeaa)DE-He213 Cancer Risk (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1421(2004), 1 vom: Jan., Seite 21-21 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1421 year:2004 number:1 month:01 pages:21-21 https://dx.doi.org/10.2165/00128413-200414210-00055 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1421 2004 1 01 21-21
allfields_unstemmed	10.2165/00128413-200414210-00055 doi (DE-627)SPR035177209 (SPR)00128413-200414210-00055-e DE-627 ger DE-627 rakwb eng Is aspirin associated with an increased pancreatic cancer risk? 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 High Risk (dpeaa)DE-He213 Aspirin (dpeaa)DE-He213 Relative Risk (dpeaa)DE-He213 Pancreatic Cancer (dpeaa)DE-He213 Cancer Risk (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1421(2004), 1 vom: Jan., Seite 21-21 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1421 year:2004 number:1 month:01 pages:21-21 https://dx.doi.org/10.2165/00128413-200414210-00055 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1421 2004 1 01 21-21
allfieldsGer	10.2165/00128413-200414210-00055 doi (DE-627)SPR035177209 (SPR)00128413-200414210-00055-e DE-627 ger DE-627 rakwb eng Is aspirin associated with an increased pancreatic cancer risk? 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 High Risk (dpeaa)DE-He213 Aspirin (dpeaa)DE-He213 Relative Risk (dpeaa)DE-He213 Pancreatic Cancer (dpeaa)DE-He213 Cancer Risk (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1421(2004), 1 vom: Jan., Seite 21-21 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1421 year:2004 number:1 month:01 pages:21-21 https://dx.doi.org/10.2165/00128413-200414210-00055 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1421 2004 1 01 21-21
allfieldsSound	10.2165/00128413-200414210-00055 doi (DE-627)SPR035177209 (SPR)00128413-200414210-00055-e DE-627 ger DE-627 rakwb eng Is aspirin associated with an increased pancreatic cancer risk? 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 High Risk (dpeaa)DE-He213 Aspirin (dpeaa)DE-He213 Relative Risk (dpeaa)DE-He213 Pancreatic Cancer (dpeaa)DE-He213 Cancer Risk (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1421(2004), 1 vom: Jan., Seite 21-21 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1421 year:2004 number:1 month:01 pages:21-21 https://dx.doi.org/10.2165/00128413-200414210-00055 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1421 2004 1 01 21-21
language	English
source	Enthalten in Inpharma weekly 1421(2004), 1 vom: Jan., Seite 21-21 volume:1421 year:2004 number:1 month:01 pages:21-21
sourceStr	Enthalten in Inpharma weekly 1421(2004), 1 vom: Jan., Seite 21-21 volume:1421 year:2004 number:1 month:01 pages:21-21
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	High Risk Aspirin Relative Risk Pancreatic Cancer Cancer Risk
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2004-01-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035177209
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035177209</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519235324.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2004 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200414210-00055</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035177209</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200414210-00055-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Is aspirin associated with an increased pancreatic cancer risk?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2004</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2004</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">High Risk</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Aspirin</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Relative Risk</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pancreatic Cancer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer Risk</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1421(2004), 1 vom: Jan., Seite 21-21</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1421</subfield><subfield code="g">year:2004</subfield><subfield code="g">number:1</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:21-21</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200414210-00055</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1421</subfield><subfield code="j">2004</subfield><subfield code="e">1</subfield><subfield code="c">01</subfield><subfield code="h">21-21</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Is aspirin associated with an increased pancreatic cancer risk? High Risk (dpeaa)DE-He213 Aspirin (dpeaa)DE-He213 Relative Risk (dpeaa)DE-He213 Pancreatic Cancer (dpeaa)DE-He213 Cancer Risk (dpeaa)DE-He213
topic	misc High Risk misc Aspirin misc Relative Risk misc Pancreatic Cancer misc Cancer Risk
spellingShingle	misc High Risk misc Aspirin misc Relative Risk misc Pancreatic Cancer misc Cancer Risk Is aspirin associated with an increased pancreatic cancer risk?
topic_unstemmed	misc High Risk misc Aspirin misc Relative Risk misc Pancreatic Cancer misc Cancer Risk
topic_browse	misc High Risk misc Aspirin misc Relative Risk misc Pancreatic Cancer misc Cancer Risk
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Is aspirin associated with an increased pancreatic cancer risk?
ctrlnum	(DE-627)SPR035177209 (SPR)00128413-200414210-00055-e
title_full	Is aspirin associated with an increased pancreatic cancer risk?
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2004
contenttype_str_mv	txt
container_start_page	21
container_volume	1421
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200414210-00055
title_sort	is aspirin associated with an increased pancreatic cancer risk?
title_auth	Is aspirin associated with an increased pancreatic cancer risk?
abstract	© Adis International Ltd 2004
abstractGer	© Adis International Ltd 2004
abstract_unstemmed	© Adis International Ltd 2004
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305
container_issue	1
title_short	Is aspirin associated with an increased pancreatic cancer risk?
url	https://dx.doi.org/10.2165/00128413-200414210-00055
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200414210-00055
up_date	2024-07-03T13:48:23.952Z
_version_	1803565928500166656
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035177209</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519235324.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2004 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200414210-00055</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035177209</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200414210-00055-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Is aspirin associated with an increased pancreatic cancer risk?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2004</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2004</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">High Risk</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Aspirin</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Relative Risk</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pancreatic Cancer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer Risk</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1421(2004), 1 vom: Jan., Seite 21-21</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1421</subfield><subfield code="g">year:2004</subfield><subfield code="g">number:1</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:21-21</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200414210-00055</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1421</subfield><subfield code="j">2004</subfield><subfield code="e">1</subfield><subfield code="c">01</subfield><subfield code="h">21-21</subfield></datafield></record></collection>
score	7.4000454

Nicht das Richtige dabei?

Schreiben Sie uns!

Is aspirin associated with an increased pancreatic cancer risk?

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?